Login / Signup
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?
Neil D Gross
Tanguy Y Seiwert
Published in:
Cancer (2024)
Keyphrases
</>
minimally invasive
coronary artery bypass
rectal cancer
healthcare
palliative care
locally advanced
lymph node
quality improvement
surgical site infection
pain management
squamous cell carcinoma
acute coronary syndrome